These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6341864)

  • 1. Carbohydrate metabolism in patients with nephrotic syndrome and normal renal function.
    Loschiavo C; Lupo A; Valvo E; Tessitore N; Ferrari S; Corgnati A; Maschio G
    Nephron; 1983; 33(4):257-61. PubMed ID: 6341864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of clusterin in renal diseases causing nephrotic syndrome.
    Ghiggeri GM; Bruschi M; Candiano G; Rastaldi MP; Scolari F; Passerini P; Musante L; Pertica N; Caridi G; Ferrario F; Perfumo F; Ponticelli C
    Kidney Int; 2002 Dec; 62(6):2184-94. PubMed ID: 12427144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of intercapillary nodular glomerulosclerosis in the absence of glucose intolerance.
    Kanwar YS; Garces J; Molitch ME
    Am J Kidney Dis; 1990 Mar; 15(3):281-3. PubMed ID: 2407111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum myeloid-related protein 8/14 in minimal change- and glomerulonephritis-related nephrotic syndrome.
    Ohara S; Kawasaki Y; Maeda R; Kanno S; Suzuki Y; Suyama K; Hosoya M
    Pediatr Int; 2016 Oct; 58(10):998-1002. PubMed ID: 26891373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular hyperpermeability in nephrotic edema.
    Rostoker G; Behar A; Lagrue G
    Nephron; 2000 Jul; 85(3):194-200. PubMed ID: 10867533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and insulin-like growth factor binding protein-1 responses to oral glucose in patients with primary hyperparathyroidism.
    Díez JJ; Grande C; Méndez J; González-Gancedo P; Iglesias P
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):27-34. PubMed ID: 16817815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation.
    Zimmerman SW
    Clin Nephrol; 1984 Jul; 22(1):32-8. PubMed ID: 6383672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course and resolution of the coagulopathy in nephrotic children.
    Alkjaersig N; Fletcher AP; Narayanan M; Robson AM
    Kidney Int; 1987 Mar; 31(3):772-80. PubMed ID: 2437352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of nephrotic syndrome in patients with glomerulonephritis.
    Sonkodi S; Tichy B; Mágori A; Ormos J
    Acta Med Hung; 1986; 43(3):311-3. PubMed ID: 3588169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
    Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
    Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression of normal lymphocyte transformation by sera of patients with minimal change nephropathy and other forms of nephrotic syndrome.
    Taube D; Chapman S; Brown Z; Williams DG
    Clin Nephrol; 1981 Jun; 15(6):286-90. PubMed ID: 7249426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
    Bruschi M; Catarsi P; Candiano G; Rastaldi MP; Musante L; Scolari F; Artero M; Carraro M; Carrea A; Caridi G; Zennaro C; Sanna-Cherchi S; Viola FB; Ferrario F; Perfumo F; Ghiggeri GM
    Kidney Int; 2003 Feb; 63(2):686-95. PubMed ID: 12631135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum albumin and growth hormone relationships in kwashiorkor and the nephrotic syndrome.
    Becker DJ; Pimstone BL; Hansen JD; Hendricks S
    J Lab Clin Med; 1971 Dec; 78(6):865-71. PubMed ID: 5171614
    [No Abstract]   [Full Text] [Related]  

  • 14. Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin.
    Gupta K; Iskandar SS; Daeihagh P; Ratliff HL; Bleyer AJ
    Nephrol Dial Transplant; 2008 May; 23(5):1595-9. PubMed ID: 18065791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate metabolism in glomerulonephritis.
    Ryabov SI; Kozhevnikov AD
    Nephron; 1981; 28(3):118-23. PubMed ID: 7029319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperlipidemia and hyperinsulinemia in kidney diseases occurring with the nephrotic syndrome].
    Razboinikov S; Tishkov I; Shipkova P; Turkolov N; Mushmov D
    Urol Nefrol (Mosk); 1979; (4):19-23. PubMed ID: 473433
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glucagon secretion in patients with nephrotic syndrome in primary glomerulonephritis during the period of renal efficiency].
    Napierała K
    Ann Acad Med Stetin; 1990; 36():113-32. PubMed ID: 2099103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chemotactic inhibitory factor in the minimal change nephrotic syndrome.
    Lin CY; Su SN
    Int J Pediatr Nephrol; 1986; 7(4):191-6. PubMed ID: 3818178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis.
    Ponticelli C; Rivolta E
    Am J Nephrol; 1990; 10 Suppl 1():105-9. PubMed ID: 2256469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.